Back to Search
Start Over
In vitro anthelmintic efficacy of inhibitors of phosphoethanolamine Methyltransferases in Haemonchus contortus
- Source :
- International Journal for Parasitology: Drugs and Drug Resistance, International Journal for Parasitology: Drugs and Drug Resistance, Vol 6, Iss 1, Pp 44-53 (2016)
- Publication Year :
- 2016
- Publisher :
- Elsevier BV, 2016.
-
Abstract
- The essential phosphobase methylation pathway for synthesis of phosphocholine is unique to nematodes, protozoa and plants, and thus an attractive antiparasitic molecular target. Herein, we screened compounds from the National Cancer Institute (Developmental Therapeutics Program Open Chemical Repository) for specific inhibitory activity against Haemonchus contortus phosphoethanolamine methyltransferases (HcPMT1 and HcPMT2), and tested candidate compounds for anthelmintic activity against adult and third-stage larvae of H. contortus. We identified compound NSC-641296 with IC50 values of 8.3 ± 1.1 μM and 5.1 ± 1.8 μM for inhibition of the catalytic activity of HcPMT1 alone and HcPMT1/HcPMT2 combination, respectively. Additionally we identified compound NSC-668394 with inhibitory IC50 values of 5.9 ± 0.9 μM and 2.8 ± 0.6 μM for HcPMT1 alone and HcPMT1/HcPMT2 combination, respectively. Of the two compounds, NSC-641296 depicted significant anthelmintic activity against third-stage larvae (IC50 = 15 ± 2.9 μM) and adult stages (IC50 = 7 ± 2.9 μM) of H. contortus, with optimal effective in vitro concentrations being 2-fold and 4-fold, respectively, lower than its cytotoxic IC50 (29 ± 2.1 μM) in a mammalian cell line. Additionally, we identified two compounds, NSC-158011 and NSC-323241, with low inhibitory activity against the combined activity of HcPMT1 and HcPMT2, but both compounds did not show any anthelmintic activity against H. contortus. The identification of NSC-641296 that specifically inhibits a unique biosynthetic pathway in H. contortus and has anthelmintic activity against both larval and adult stages of H. contortus, provides impetus for the development of urgently needed new efficacious anthelmintics to address the prevailing problem of anthelmintic-resistant H. contortus.<br />Graphical abstract<br />Highlights • NSC-641296 and NSC-668394 inhibit HcPMT1 and HcPMT2 enzymes in Haemonchus contortus. • NSC-641296 has in vitro anthelmintic activity against larvae and adult H. contortus. • H. contortus HcPMT1 and HcPMT2 are two unique targets for anthelmintic development.
- Subjects :
- 0301 basic medicine
Antinematodal agent
Methyltransferase
Antiparasitic
medicine.drug_class
Drug Evaluation, Preclinical
Pharmacology
Biology
Article
lcsh:Infectious and parasitic diseases
Cell Line
Inhibitory Concentration 50
03 medical and health sciences
chemistry.chemical_compound
Haemonchus contortus
Drug Discovery
parasitic diseases
medicine
Animals
lcsh:RC109-216
Pharmacology (medical)
Anthelmintic
Chemical inhibitors
Mode of action
IC50
Phosphocholine
030102 biochemistry & molecular biology
Phosphoethanolamine N-methyltransferase
Antinematodal Agents
Anthelmintic activity
Methyltransferases
biology.organism_classification
Phosphatidylcholine
030104 developmental biology
Infectious Diseases
Biochemistry
chemistry
Larva
Haemonchus
Parasitology
Sequence Alignment
medicine.drug
Subjects
Details
- ISSN :
- 22113207
- Volume :
- 6
- Database :
- OpenAIRE
- Journal :
- International Journal for Parasitology: Drugs and Drug Resistance
- Accession number :
- edsair.doi.dedup.....4072603f2a48617ba0b0ce2ee381eb94
- Full Text :
- https://doi.org/10.1016/j.ijpddr.2016.01.002